Google
ACHV — ACHIEVE LIFE SCIENCES INC (Healthcare >> Biotechnology)
ACHV FAQ
What is ACHV's ROE?
ACHIEVE LIFE SCIENCES INC reports a Return on Equity (ROE) of -486.88%.
What is ACHV's dividend yield?
ACHIEVE LIFE SCIENCES INC offers a dividend yield of 0.00%.
What is ACHV's Deepscope Quality Score?
Deepscope rates ACHV's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ACHV?
Deepscope's AI Timing Score for ACHV is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ACHV belong to?
ACHIEVE LIFE SCIENCES INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 5.13
Price
-0.16
(-3.02%)
Day Change
|
|
|---|
ACHV, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.13 |
| PBV / Sector |
49.32 / 4.63
|
| Earning Per Share | -0.51 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
7.43 M
|
| Average 1W Daily Value |
5.99 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
39% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:25 |
| Symbol | ACHV |
| Name | ACHIEVE LIFE SCIENCES INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 102.66 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 526.64 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 22722 29th Dr. SE, Bothell, WA, United States, 98021
Phone: 604 210 2217
Website: https://www.achievelifesciences.com
Sector: Healthcare >> Biotechnology
Description: Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
